Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

CA Cancer Journal for Clinicians

Volumn 59, Issue 1, 2009, Pages 8-24

  Lawenda, Brian D ^a,b,c,d   Mondry, Tammy E ^e   Johnstone, Peter A S ^d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Breast Health Center   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e New Horizons Physical Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMY; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CHRONIC DISEASE; CLINICAL TRIAL; COMPLETE DECONGESTIVE THERAPY; COMPRESSION GARMENT; CONSERVATIVE TREATMENT; DISEASE EXACERBATION; DISEASE SEVERITY; HEART FAILURE; HUMAN; HYPERBARIC OXYGEN; LIPOSUCTION; LOW LEVEL LASER THERAPY; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOVENOUS ANASTOMOSIS; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICROSURGERY; PARTIAL MASTECTOMY; PATHOPHYSIOLOGY; PELVIS CANCER; PHYSIOLOGY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

CHRONIC DISEASE; HUMANS; LASER THERAPY, LOW-LEVEL; LYMPH NODE EXCISION; LYMPHEDEMA; PHYSICAL THERAPY MODALITIES; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN CARE; TREATMENT OUTCOME;

EID: 58849155128     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.20001     Document Type: Review

References (105)

1. Zuther E. Pathology. In: Von Rohr M, ed. Lymphedema Management: The Comprehensive Guide for Practitioners. New York: Thieme Medical Publishers, Inc; 2005:45-99.
2. Foldi M, Foldi E. Physiology and pathophysiology of the lymphatic system. In: Foldi E, Foldi M, eds. Foldi's Textbook of Lymphology. 2nd ed. Munich: Elsevier; 2006:179-222.
3. Kubik S, Kretz O. Anatomy of the lymphatic system. In: Foldi M, Foldi E, eds. Foldi's Textbook of Lymphology. 2nd ed. Munich: Elsevier; 2006:1-50.
4. Zuther E. Anatomy. In: Von Rohr M, ed. Lymphedema Management: The Comprehensive Guide for Practitioners. New York: Thieme Medical Publishers; 2005:1-28.
5. Zuther E. Physiology. In: Von Rohr M, ed. Lymphedema Management: The Comprehensive Guide for Practitioners. New York: Thieme Medical Publishers, Inc; 2005:29-44.
6. Bates DO, Levick JR, Mortimer PS. Change in macromolecular composition of interstitial fluid from swollen arms after breast cancer treatment, and its implications. Clin Sci (Lond). 1993;85:737-746.
7. Sussman C, Bates-Jensen B. Wound Care: A Collaborative Practice Manual for Health Professionals. 3rd ed. New York: Lippincott Williams & Wilkins; 2006.
8. Brorson H, Ohlin K, Olsson G, et al. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat Res Biol. 2006;4:199-210.
9. Brorson H. Adipose tissue in lymphedema: the ignorance of adipose tissue in lymphedema. Lymphology. 2004;37:175-177.
10. Lacovara JE, Yoder LH. Secondary lymphedema in the cancer patient. Medsurg Nurs. 2006;15:302-306; quiz 307.
11. Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 2003;69:209-211; discussion 212.
12. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748-752.
13. Bani HA, Fasching PA, Lux MM, et al. Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns. 2007;66:311-318.
14. Borup Christensen S, Lundgren E. Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial. Acta Chir Scand. 1989;155:515-519.
15. Edwards TL. Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg. 2000;70:412-418.
16. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580-584.
17. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer. 1997;33:193-199.
18. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93:96-111.
19. Meric F, Buchholz TA, Mirza NQ, et al. Long-term complications associated with breast-conservation surgery and radiotherapy [see comment]. Ann Surg Oncol. 2002;9:543-549.
20. Mazeron JJ, Otmezguine Y, Huart J, Pierquin B. Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients. Lancet. 1985;1:1387.
21. Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy [erratum appears in Int J Radiat Oncol Biol Phys. 2003;56:604]. Int J Radiat Oncol Biol Phys. 2003;55:1209-1215.
22. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657-3663.
23. Langer I, Guller U, Berclaz G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245:452-461.
24. Deo SV, Ray S, Rath GK, et al. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer. 2004;41:8-12.
25. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491-500.
26. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279-293.
27. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405-411.
28. Beaulac SM, McNair LA, Scott TE, et al. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002;137:1253-1257.
29. Hoebers FJ, Borger JH, Hart AA, Peterse JL, Th EJ, Lebesque JV. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes. Cancer. 2000;88:1633-1642.
30. Galper S, Recht A, Silver B, et al. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys. 2000;48:125-132.
31. Deutsch M, Land S, Begovic M, Sharif S. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 2008;70:1020-1024.
32. Chang DT, Feigenberg SJ, Indelicato DJ, et al. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection. Int J Radiat Oncol Biol Phys. 2007;67:1043-1051.
33. Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol. 2004;11:573-580.
34. Golshan M, Smith B. Prevention and management of arm lymphedema in the patient with breast cancer [see comment]. J Support Oncol. 2006;4:381-386.
35. Graham P, Jagavkar R, Browne L, Millar E. Supraclavicular radiotherapy must be limited laterally by the coracoid to avoid significant adjuvant breast nodal radiotherapy lymphoedema risk. Australas Radiol. 2006;50:578-582.
36. Kwak JY, Kim EK, Chung SY, et al. Unilateral breast edema: spectrum of etiologies and imaging appearances. Yonsei Med J. 2005;46:1-7.
37. Oraedu CO, Pinnapureddy P, Alrawi S, Acinapura AJ, Raju R. Congestive heart failure mimicking inflammatory breast carcinoma: a case report and review of the literature. Breast J. 2001;7:117-119.
38. Doyle AJ. Unilateral breast edema in congestive heart failure - a mimic of diffuse carcinoma. Australas Radiol. 1991;35:274-275.
39. Meek AG. Breast radiotherapy and lymphedema. Cancer. 1998;83:2788-2797.
40. O'Brien PJ. Integrated Survivorship Care. Presented at the Fourth Annual Orlando Breast Cancer Conference, Orlando, Florida, March 31-April 1, 2007. https://www.mdeducationconferences.com/pdf/faculty forms/2007BC.pdf.
41. Ronka RH, Pamilo MS, von Smitten KA, Leidenius MH. Breast lymphedema after breast conserving treatment. Acta Oncol. 2004;43:551-557.
42. Wratten CR, O'Brien PC, Hamilton CS, Bill D, Kilmurray J, Denham JW. Breast edema in patients undergoing breast-conserving treatment for breast cancer: assessment via high frequency ultrasound. Breast J. 2007;13:266-273.
43. Armer JM, Stewart BR. A comparison of 4 diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3:208-217.
44. Pezner RD, Patterson MP, Hill LR, Desai KR, Vora N, Lipsett JA. Breast edema in patients treated conservatively for stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 1985;11:1765-1768.
45. Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol. 1998;174:504-509.
46. Gerdin E, Cnattingius S, Johnson P. Complications after radiotherapy and radical hysterectomy in early-stage cervical carcinoma. Acta Obstet Gynecol Scand. 1995;74:554-561.
47. Hong JH, Tsai CS, Lai CH, et al. Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis. Int J Radiat Oncol Biol Phys. 2002;53:1284-1290.
48. Nunns D, Williamson K, Swaney L, Davy M. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma. Int J Gynecol Cancer. 2000;10:233-238.
49. Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. A retrospective review of nodal treatment for vulvar cancer. Am J Clin Oncol. 1993;16:38-42.
50. van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev. 2006;3:CD003752.
51. Pilepich MV, Asbell SO, Mulholland GS, Pajak T. Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group. Prostate. 1984;5:471-476.
52. Wrone DA, Tanabe KK, Cosimi AB, Gadd MA, Souba WW, Sober AJ. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol. 2000;136:511-514.
53. Starritt EC, Joseph D, McKinnon JG, Lo SK, de Wilt JH, Thompson JF. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg. 2004;240:866-874.
54. Sable M, Griffith K, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728-735.
55. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370-379.
56. Weissleder H, Schuchhardt C. Lymphedema Diagnosis and Therapy. 2nd ed. Bonn, Germany: Kagerer Kommunikation; 1997.
57. Brennan MJ, Weitz J. Lymphedema 30 years after radical mastectomy. Am J Phys Med Rehabil. 1992;71:12-14.
58. Swedborg I. Effects of treatment with an elastic sleeve and intermittent pneumatic compression in post-mastectomy patients with lymphoedema of the arm. Scand J Rehabil Med. 1984;16:35-41.
59. Deltombe T, Jamart J, Recloux S, et al. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology. 2007;40:26-34.
60. Warren AG, Janz BA, Slavin SA, Borud LJ. The use of bioimpedance analysis to evaluate lymphedema. Ann Plast Surg. 2007;58:541-543.
61. Clarke D, Martinez A, Cox RS, Goffinet DR. Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer. 1982;49:2295-2299.
62. Carati CJ, Anderson SN, Gannon BJ, Piller NB. Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial [erratum appears in Cancer. 2003;98:2742]. Cancer. 2003;98:1114-1122.
63. Teas J, Cunningham JE, Cone L, et al. Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study. J Womens Health (Larchmt). 2004;13:1008-1018.
64. Carl UM, Hartmann KA. Hyperbaric oxygen treatment for symptomatic breast edema after radiation therapy. Undersea Hyperb Med. 1998;25:233-234.
65. Piller NB, Thelander A. Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31:74-86.
66. Kaviani A, Fateh M, Yousefi Nooraie R, Alinagi-zadeh MR, Ataie-Fashtami L. Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med Sci. 2006;21:90-94.
67. Campisi C, Eretta C, Pertile D, et al. Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery. 2007;27:333-338.
68. Damstra RJ, Voesten HG, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat. 2008 Feb 13 [Epub ahead of print].
69. Baumeister RG, Frick A, Baumeister RGH. [The microsurgical lymph vessel transplantation]. Handchir Mikrochir Plast Chir. 2003;35:202-209.
70. Brorson H. Liposuction in arm lymphedema treatment. Scand J Surg. 2003;92:287-295.
71. Brorson H, Ohlin K, Olsson G, Langstrom G, Wiklund I, Svensson H. Quality of life following liposuction and conservative treatment of arm lymphedema. Lymphology. 2006;39:8-25.
72. Brorson H, Ohlin K, Svensson B, Svensson H. Controlled compression therapy and liposuction treatment for lower extremity lymphedema. Lymphology. 2008;41:52-63.
73. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema; Consensus document of the International Society of Lymphology. International Society of Lymphology. Available at: http://www.u.arizona.edu/~witte/ISL.htm. Accessed June 18, 2008.
74. Ko DS, Lerner R, Klose G, Cosimi AB. Effective treatment of lymphedema of the extremities. Arch Surg. 1998;133:452-458.
75. Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol. 2007;14:1904-1908.
76. Koul R, Dufan T, Russell C, et al. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys. 2007;67:841-846.
77. Pinell XA, Kirkpatrick SH, Hawkins K, et al. Manipulative therapy of secondary lymphedema in the presence of locoregional tumors. Cancer. 2008;112:950-954.
78. Karadibak D, Yavuzsen T, Saydam S. Prospective trial of intensive decongestive physiotherapy for upper extremity lymphedema. J Surg Oncol. 2008;97:572-577.
79. Yamamoto R, Yamamoto T. Effectiveness of the treatment-phase of 2-phase complex decongestive physiotherapy for the treatment of extremity lymphedema. Int J Clin Oncol. 2007;12:463-468.
80. Hinrichs CS, Gibbs JF, Driscoll D, et al. The effectiveness of complete decongestive physiotherapy for the treatment of lymphedema following groin dissection for melanoma. J Surg Oncol. 2004;85:187-192.
81. Thomas RC, Hawkins K, Kirkpatrick SH, Mondry TE, Gabram-Mendola S, Johnstone PA. Reduction of lymphedema using complete decongestive therapy: roles of prior radiation therapy and extent of axillary dissection. J Soc Integr Oncol. 2007;5:87-91.
82. Foldi M, Strobenreuther R. Foundations of Manual Lymph Drainage. 3rd ed. St. Louis: Elsevier Mosby; 2005.
83. Dery MA, Yonuschot G, Winterson BJ. The effects of manually applied intermittent pulsation pressure to rat ventral thorax on lymph transport. Lymphology. 2000;33:58-61.
84. Andersen L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage-a randomized study. Acta Oncol. 2000;39:399-405.
85. McNeely ML, Magee DJ, Lees AW, et al. The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial. Breast Cancer Res Treat. 2004;86:95-106.
86. Badger C, Preston N, Seers K, Mortimer P. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004;(4):CD003141.
87. Moseley AL, Piller NB, Carati CJ. The effect of gentle arm exercise and deep breathing on secondary arm lymphedema. Lymphology. 2005;38:136-145.
88. Markes M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2006;(4):CD005001.
89. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors [see comment] [erratum appears in J Clin Oncol. 2006;24:3716]. J Clin Oncol. 2006;24:2765-2772.
90. Wittlinger G, Wittlinger H. Textbook of Dr. Vodder's Manual Lymph Drainage. Heidelberg, Germany: Springer-Verlag; 1998.
91. Burt J, White G. Lymphedema: A Breast Cancer Patient's Guide to Prevention and Healing. Alameda, CA: Hunter House, Inc.; 1999.
92. Kasseroller R. Compendium of Dr. Vodder's Manual Lymph Drainage. Heidelberg, Germany: Springer-Verlag; 1998.
93. Kelly DG. A Primer on Lymphedema. Upper Saddle River, NJ: Pearson Education, Inc; 2002.
94. Foldi M, Foldi E, Dubik S. Textbook of Lymphology for Physicians and Lymphedema Therapists. Munich: Urban & Fischer; 2003.
95. Foldi E. The treatment of lymphedema. Cancer. 1998;83:2833-2834.
96. Godette K, Mondry TE, Johnstone PA. Can manual treatment of lymphedema promote metastasis? J Soc Integr Oncol. 2006;4:8-12.
97. Johansson K, Albertsson M, Ingvar C, Ekdahl C. Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema [see comment]. Lymphology. 1999;32:103-110.
98. Johnstone PA, Hawkins K, Hood S. Role of patient adherence in maintenance of results after manipulative therapy for lymphedema. J Soc Integr Oncol. 2006;4:125-129.
99. Mondry TE, Riffenburgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J 2004;10:42-48; discussion 17-49.
100. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13:904-911.
101. McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer. 2005;104:457-466.
102. National Lymphedema Network. Lymphedema risk-reduction practices. Available at: http://www.lymphnet.org/pdfDocs/nlnriskreduction.pdf. Accessed June 18, 2008.
103. Ridner SH. Pretreatment lymphedema education and identified educational resources in breast cancer patients. Patient Educ Couns. 2006;61:72-79.
104. Greene AK, Borud L, Slavin SA. Blood pressure monitoring and venipuncture in the lymphedematous extremity. Plast Reconstr Surg. 2005;116:2058-2059.
105. National Lymphedema Network. Air Travel. Available at: http://www.lymphnet.org/pdfDocs/nlnairtravel.pdf. Accessed June 18, 2008.